Pentasa package

Notice: Product images are for illustration purposes only and may differ from the medication you receive. Packaging and appearance may vary depending on the country of origin, and generic medications may be supplied by different manufacturers. The medication, strength, and active ingredients will match your prescription. At the Canadian Pharmacy Store we prioritize your health and safety by working with licensed pharmacy partners to provide safe, high-quality medications.

Pentasa (Mesalamine)

Apriso ER

Mesalamine

Sourced from Canada Source: Canada
Prescription Required
Select product strength & quantity:

Pentasa

Mesalamine

Sourced from Canada Source: Canada
Prescription Required
Select product strength & quantity:

Pentasa

Mesalamine

Sourced from United Kingdom Source: United Kingdom
Prescription Required
Select product strength & quantity:
Select Strength & Quantity

Choose the strength, form, and package size that match your prescription.

Send Your Prescription

Upload your prescription online, request a transfer, or have your doctor fax us.

Pharmacist Review & Delivery

Reviewed by a licensed pharmacist and shipped to your U.S. address with tracking. Shipping details.

Description

Pentasa (mesalamine) is an aminosalicylate listed in our Digestive health medications directory and prescribed for specified inflammatory bowel disease (1.1) (2.1). Administered via the oral route, Pentasa is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.

Pentasa is a medication containing the active pharmaceutical ingredient mesalamine, classified pharmacologically as an aminosalicylate (2.1). It is clinically indicated for the management of specified inflammatory bowel disease as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).

Within the Digestive health medications section of our catalogue, patients and prescribers frequently review Pentasa alongside related therapies such as Lialda (Mesalamine), Rowasa (Mesalamine), Mezavant (Mesalamine), and Salofalk (Mesalamine).

Official Indications and Usage

Mesalamine delayed-release tablets are indicated for the (1.1):

  • Induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis.
  • Treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg..

Mechanism of Action and Pharmacology

The mechanism of action of mesalamine is not fully understood, but it appears to have a topical anti-inflammatory effect on the colonic epithelial cells. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase and lipoxygenase pathways, is increased in patients with ulcerative colitis, and it is possible that mesalamine diminishes inflammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon. (1.1)

What is Inflammatory bowel disease?

Inflammatory bowel disease includes Crohn disease and ulcerative colitis. Treatment depends on diagnosis, disease location, severity, and prior response. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Inflammatory bowel disease condition guide for appointment questions and related therapies (2.1).

Ordering Pentasa from Canada for U.S. Delivery

U.S. patients can order Pentasa (Mesalamine) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.

Step 1

Send Your Prescription

Step 2

Pharmacist Safety Check

  • Multi-point dosing and interaction review completed in under 1 business day.
  • Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
  • Verified under our Pharmacy Safety Standards.
Step 3

$14.99 USD Tracked Parcel

  • Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
  • Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
  • Review full shipping and delivery details.
Step 4

U.S. Street Delivery & Payment

  • Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
  • You see and approve the country of origin upfront before your card is charged.
  • Report any delayed or damaged parcel within 48 hours for prompt resolution.

Fact Table

Clinical Specification Details
Brand / Product Name Pentasa
Chemical / Generic Name Mesalamine
Pharmacological Class Aminosalicylate
Therapeutic Category Digestive health medications
Same-Ingredient Catalogue Entries Lialda (Mesalamine), Rowasa (Mesalamine), Mezavant (Mesalamine), Salofalk (Mesalamine)
Protein Binding ~43% (1.1)
Legal Status Rx-Only (Prescription Required)
Regulatory Reference Authorities U.S. FDA (DailyMed), Health Canada (DPD), NLM MedlinePlus
Routes of Administration Oral
Dosage Forms & Strengths Mesalamine Delayed-release Tablets USP, 1.2 g are pale red-brown, oval-shaped, biconvex, bevel film-coated tablets debossed with the '711' on one side and
Primary Indications Specified Inflammatory Bowel Disease
Pregnancy & Breastfeeding Consult Doctor / Prescriber before use
FDA UNII Identifier 4Q81I59GXC
NLM RxNorm Concept ID (RxCUI) 686429
FDA Application License ANDA091640
Official DailyMed SetID 14ac4435-903b-41f5-a3c4-8c73de3e4cef
Catalogue Index Links Letter P Index · All Medications · All Categories

Directions

Dosage and Administration Overview

Administration Instructions (1.1):

  • Evaluate renal function prior to initiation of mesalamine and periodically while on therapy.
  • Swallow mesalamine delayed-release tablets whole; do not split or crush.
  • Administer mesalamine delayed-release tablets with food.
  • Drink an adequate amount of fluids. Adults.
  • The recommended dosage for the induction of remission in adult patients with mildly to moderately active ulcerative colitis is 2.4 g to 4.8 g (two to four 1.2-g tablets) taken once daily.

Presentations and Strengths

Mesalamine Delayed-release Tablets USP, 1.2 g are pale red-brown, oval-shaped, biconvex, bevel film-coated tablets debossed with the '711' on one side and plain on other side. Delayed-Release Tablets: 1.2 g. (1.1)

Administration Guidance

Take Pentasa orally at the same time(s) each day as directed on your prescription label (1.1). Check with your pharmacist whether your specific formulation should be taken with a meal or on an empty stomach, and swallow extended-release or film-coated tablets whole without crushing, chewing, or splitting unless the tablet is scored and your prescriber has instructed you to do so.

Missed Dose Guidance

If you miss a scheduled dose of Pentasa, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).

Ingredients

Active Pharmaceutical Ingredient

The active ingredient in Pentasa is mesalamine (2.1). Other catalogue entries containing mesalamine include Lialda (Mesalamine), Rowasa (Mesalamine), Mezavant (Mesalamine), and Salofalk (Mesalamine).

Inactive Ingredients (Excipients)

According to the U.S. FDA product labeling, formulation excipients include carboxymethylcellulose sodium, colloidal silicon dioxide, hypromellose, iron oxide red, iron oxide yellow, magnesium stearate, methacrylic acid copolymer, microcrystalline cellulose, polyethylene glycol, sodium starch glycolate, triethyl citrate, talc and titanium dioxide (1.1). Inactive ingredients can vary slightly between different manufacturers and international or generic presentations; review the dispensed carton if you have known excipient sensitivities.

Cautions and important safety information

Contraindications

Mesalamine delayed-release tablets are contraindicated in patients with known or suspected hypersensitivity to salicylates, aminosalicylates, or to any of the ingredients of mesalamine delayed-release tablets. (1.1)

Key Clinical Precautions

Before starting or continuing Pentasa, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):

  • Hypersensitivity and anaphylaxis: Serious allergic reactions, including anaphylaxis, angioedema, and severe rash, have been reported. Discontinue use and seek immediate medical care if swelling of the face, lips, tongue, or throat or difficulty breathing occurs.
  • Renal function and acute kidney injury: Changes in serum creatinine or estimated glomerular filtration rate (eGFR) can occur, particularly in patients with volume depletion, chronic kidney disease, or concomitant use of NSAIDs, ACE inhibitors, ARBs, or diuretics. Renal function should be assessed prior to initiation and periodically thereafter.
  • Severe cutaneous adverse reactions (SCARs): Rare but serious skin reactions such as Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) require immediate discontinuation at the first sign of a blistering rash, mucosal lesions, or fever.

Pregnancy, Lactation, and Special Populations

Published data from meta-analyses, cohort studies, and case series on the use of mesalamine during pregnancy have not reliably informed an association with mesalamine and major birth defects, miscarriage, or adverse maternal or fetal outcomes. There are adverse effects on maternal and fetal outcomes associated with ulcerative colitis in pregnancy. In animal reproduction studies, there were no adverse developmental outcomes with administration of oral mesalamine during organogenesis to pregnant rats and rabbits at doses 1.8 and 2.9 times, respectively, the maximum recommended human dose. (1.1)

Interactions

Official Drug Interaction Overview

  • Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions.
  • Azathioprine or 6-Mercaptopurine: Increased risk of blood dyscrasias; monitor complete blood cell counts and platelet counts. (1.1)

Important Interaction Categories

Concomitant use of Pentasa with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):

  • Nonsteroidal anti-inflammatory drugs (NSAIDs in our Pain and inflammation directory, such as Celebrex (Celecoxib) or Meloxicam): Combining NSAIDs with this medication may reduce renal perfusion, diminish antihypertensive or diuretic efficacy, or increase the risk of gastrointestinal bleeding and acute kidney injury.

Side effects

Like all medications, Pentasa can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):

  • Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; taking oral doses with food (when permitted by the label) may help.
  • Vomiting: Persistent vomiting that prevents fluid intake should be reported to your clinician to prevent dehydration.
  • Diarrhea (loose stools): Maintain adequate fluid and electrolyte intake; contact your prescriber if diarrhea is severe or persistent.
  • Headache: Commonly reported during initial treatment; often improves as your body adjusts to the medication.
  • Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
  • Drowsiness or somnolence: Use caution with driving or tasks requiring alertness until you know how this medication affects you.

Clinical Trial and Postmarketing Adverse Reactions

The following clinically significant adverse reactions are described elsewhere in labeling (1.1):

  • Renal impairment, including renal failure.
  • Mesalamine-induced acute intolerance syndrome.
  • Hypersensitivity reactions.
  • Hepatic failure.
  • Severe cutaneous adverse reactions.
  • Upper gastrointestinal tract obstruction.
  • Photosensitivity.
  • Nephrolithiasis Most common adverse reactions in:
  • Adults (≥2%) are headache, flatulence, liver function test abnormal, abdominal pain, and diarrhea.
  • Pediatric patients (≥5%) are abdominal pain, upper respiratory tract infection, vomiting, anemia, headache and viral infection.

When to Seek Immediate Medical Attention

Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).

Storage and handling

Mesalamine Delayed-Release Tablets USP, 1.2 g are pale red-brown, oval-shaped, biconvex, bevel film-coated tablets debossed with the '711' on one side and plain on other side and are supplied as follows: Cartons of 30 delayed-release tablets (10 delayed-release tablets each blister pack x 3), NDC 0904-6832-04 warning: This Unit Dose package is not child resistant and is Intended for Institutional Use Only. Keep this and all drugs out of the reach of children. Storage Store at 20°C to 25°C (68°F to 77°F). Dispense in a tight, light-resistant container. (1.1)

Store Pentasa in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).

What is a generic drug?

A generic medication contains the exact same active pharmaceutical ingredient (mesalamine) as its brand-name counterpart and is formulated to deliver the same dosage strength, route of administration, safety profile, quality, and therapeutic performance (2.1). Regulatory authorities require generic manufacturers to demonstrate bioequivalence, meaning the generic medication releases its active ingredient into the bloodstream at virtually the same rate and to the same extent as the innovator brand.

While a generic tablet, capsule, or inhaler may differ in color, shape, scoring, or packaging due to trademark laws that govern brand appearance, its clinical mechanism and active ingredient match the reference medicine. Because generic manufacturers do not repeat the initial discovery and multi-phase clinical trial investments of the original brand, generic equivalents offer substantial cost savings for patients paying out of pocket.

Canadian Pharmacy Store delivers prescription and over-the-counter medications to U.S. residents. Browse our Digestive health medications directory, explore all medications A-Z, review how ordering works and prescription requirements, or call 1-888-868-1920 for personal assistance matching your prescription.

Frequently Asked Questions About Pentasa

What is Pentasa and what active ingredient does it contain?

Pentasa is an aminosalicylate containing the active pharmaceutical ingredient mesalamine. It is supplied for oral administration and requires a valid prescription where applicable.

How does Pentasa work in the body?

The mechanism of action of mesalamine is not fully understood, but it appears to have a topical anti-inflammatory effect on the colonic epithelial cells. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase and lipoxygenase pathways, is increased in patients with ulcerative colitis, and it is possible that mesalamine diminishes inflammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon.

What conditions is Pentasa prescribed to treat?

Pentasa is primarily indicated for specified inflammatory bowel disease. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.

How should I take or use Pentasa?

Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Pentasa is administered via the oral route. Take it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.

What are the most common side effects of Pentasa?

Commonly reported side effects of Pentasa include feeling sick, vomiting, loose stools, headache, dizziness, and sleepiness. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.

What medications or substances can interact with Pentasa?

Important interaction categories for Pentasa include nonsteroidal anti-inflammatory medicines. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.

Can Pentasa be used during pregnancy or breastfeeding?

If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Pentasa to weigh the clinical benefits and potential risks.

Do I need a prescription to buy Pentasa online from Canada?

Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Pentasa (Mesalamine) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).

Does Pentasa have a generic equivalent (Mesalamine) at a Canada pharmacy?

Yes. A lower-cost generic equivalent (Mesalamine) containing Mesalamine is available alongside brand-name Pentasa in our Canada pharmacy catalogue.

How is Pentasa shipped to U.S. residents, and how much does shipping cost?

Pentasa ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.

How can I send or transfer my Pentasa prescription, or ask about an unlisted strength?

You can upload a clear photo or PDF of your Pentasa prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.

References & Official Sources

Clinical, pharmacological, and safety facts for Pentasa (Mesalamine) are compiled directly from official regulatory prescribing labels and primary biomedical databases:

  1. (1.1) mesalamine. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
  2. (2.1) MedlinePlus Medical Encyclopedia: Crohn's Disease. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
  3. (3.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).

Related Condition Guides

Related Guides

Call 1-888-868-1920Help